Initial Cell Culture pH Control for Antibody TAF Glycoforms
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need in the biopharmaceutical industry for simple and efficient methods to manipulate and control the levels of total afucosylated (TAF) glycoforms during recombinant production of therapeutic antibodies, as existing methods have not effectively addressed the impact of initial pH on glycoform profiles.
Innovation Solution
Maintaining a specific initial pH during the initial cell culture period, typically 4 to 6 days post-inoculation, to modulate the levels of TAF glycoforms in recombinantly-produced glycosylated proteins, with pH ranges between 6.5 and 7.5, and adjusting pH control settings accordingly.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional cell culture pH control methods are used, then late-stage pH is maintained, but TAF glycoform levels cannot be effectively controlled
Solution Approach 1:
The patent applies preliminary action by controlling the pH during the initial cell culture period (days 0-6) before the majority of antibody production occurs. This early pH control establishes the glycoform profile that persists through later culture stages, allowing TAF glycoform levels to be predetermined and controlled without complex late-stage interventions.
2Manufacturing precision
If initial pH is controlled to modulate TAF glycoform levels, then glycoform precision is improved, but process monitoring complexity increases
Solution Approach 1:
The patent applies parameter changes by systematically varying the initial pH setpoint (e.g., pH 6.8, 7.0, 7.2, 7.4) during the initial cell culture period to achieve different TAF glycoform levels. This establishes a clear relationship between pH parameter and glycoform outcome, enabling precise control through simple parameter adjustment rather than complex process interventions.
Data Source
AI summary
Provided herein are methods of modulating the levels of total afucosylated (TAF) glycoforms of a recombinant glycosylated protein produced by glycosylation-competent cells in a cell culture. In exemplary embodiments, the methods comprise maintaining the cell culture at an initial set point pH for an initial cell culture period. Related compositions comprising glycosylated proteins and TAF glycoforms thereof are also provided herein.